The second most common cancer was endometrial cancer, in 26.35% of cases (78/296), where 46.1% (36/78) corresponded to no variant being identified; 28.2% (22/78) to variants in non-MMR genes, and 25.6% (20/78) to variants in MMR genes. This evidence concerns the gene MRC1 and cancer.